California hospital system Sutter Health has been sued a second time this summer over the fees charged within its $3.7 billion 403(b) retirement plan.
The two class-action cases were brought by law firms that have become well-known in recent retirement plan litigation: Capozzi Adler and Shepherd Finkelman Miller & Shah. The former is behind many of the new retirement-plan lawsuits filed so far this year.
Both of the lawsuits point to allegedly excessive investment management fees, as the plan did not include the lowest-cost investment options available. The July case brought by Capozzi Adler calls out net fees in most of the plan’s investments that were higher than average costs for comparable mutual funds.
The more recent case from Shepherd Finkelman, however, focuses most of its attention on the actively managed Fidelity Freedom Target Date series, which accounts for about two-thirds of the plan’s assets, according to the complaint. The share class of that product used in the Sutter Health plan is as much as eight times more expensive than the lowest-fee share class of Fidelity’s passively managed Freedom Index series, the complaint notes.
But the case also takes aim at the use of active management in general, calling Fidelity’s allocation to certain asset classes risky and pointing to long-term underperformance in the series. The use of tactical rebalancing in the active series, which allows portfolio managers to move allocations by as much as 10 percentage points, further adds to risk, the plaintiffs in the lawsuit allege.
“In a departure from the accepted wisdom that target date funds should maintain pre-set allocations, Fidelity encouraged its portfolio managers to attempt to time market shifts in order to locate underpriced securities, which the firm dubs ‘active asset allocation,’” the complaint reads.
Despite that allegation, use of tactical rebalancing in target-date series has become a standard practice among fund sponsors.
The more recent case also points to several of the plan’s investment options lagging their benchmarks in recent years, including the Parnassus Core Equity, Dodge & Cox Stock and Lazard Emerging Markets Equity funds.
The case also cites higher-than-average record-keeping fees charged to plan participants, at a flat rate of $34 per year. Based on the level of assets in the plan, the sponsor could have negotiated a fee ranging from $14 to $21 per year for each participant, the complaint stated.
As of the end of 2018, there were more than 73,000 participants in the plan, according to the September complaint.
Sutter Health declined to comment on the lawsuit.
While industry statistics pointing to a succession crisis can cause alarm, advisor-owners should be free to consider a middle path between staying solo and catching the surging wave of M&A.
New joint research by T. Rowe Price, MIT, and Stanford University finds more diverse asset allocations among older participants.
With its asset pipeline bursting past $13 billion, Farther is looking to build more momentum with three new managing directors.
A Department of Labor proposal to scrap a regulatory provision under ERISA could create uncertainty for fiduciaries, the trade association argues.
"We continue to feel confident about our ability to capture 90%," LPL CEO Rich Steinmeier told analysts during the firm's 2nd quarter earnings call.
Orion's Tom Wilson on delivering coordinated, high-touch service in a world where returns alone no longer set you apart.
Barely a decade old, registered index-linked annuities have quickly surged in popularity, thanks to their unique blend of protection and growth potential—an appealing option for investors looking to chart a steadier course through today's choppy market waters, says Myles Lambert, Brighthouse Financial.
